3,4-二氢异喹啉-1(2H)-酮 | 1196-38-9

• 物质功能分类: 医药中间体 - 异喹啉类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 中文名称: 3,4-二氢异喹啉-1(2H)-酮
• 中文别名: 3,4-二氢-2H-异喹啉-1-酮；3,4-二氢异喹啉-1-酮；3,4-二氢异喹啉-1(2H)酮
• 英文名称: 3,4-dihydroisoquinolin-1(2H)-one
• 英文别名: 3,4-dihydro-2H-isoquinolin-1-one；3,4-dihydro-1(2H)-isoquinolinone；3,4-dihydroisoquinoline-1(2H)-one；3,4-dihydro-1H-isoquinolin-1-one
• CAS: 1196-38-9
• 化学式: C₉H₉NO
• mdl: MFCD00853963
• 分子量: 147.177
• InChiKey: YWPMKTWUFVOFPL-UHFFFAOYSA-N

物化性质

• 熔点：
  166 °C
• 沸点：
  138-143 °C(Press: 0.3 Torr)
• 密度：
  1.142

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  11
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存放于惰性气体中，避免接触空气。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3,4-Dihydro-2H-isoquinolin-1-one
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3,4-Dihydro-2H-isoquinolin-1-one
CAS number: 1196-38-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H9NO
Molecular weight: 147.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3,4-二氢异喹啉-1(2H)-酮 在 palladium on activated charcoal 盐酸 、 polyphosphate ester 、 硫酸 、 氢气 、 硝酸 作用下， 以 甲醇 、 氯仿 、 水 、 溶剂黄146 为溶剂， 反应 28.0h， 生成 9-Amino-6,11-dihydro-5H-pyrrolo<2,1-b><3>benzazepin-11-one
  参考文献：
  名称：

  Synthesis, chemistry and photochemical substitutions of 6,11-dihydro-5H-pyrrolo[2,1-b][3]benzazepin-11-ones

  摘要：

  DOI：

  10.1021/jo00167a015
• 作为产物：
  描述：

  2-(氰基甲基)苯甲酸 在 乙醇 、 镍 、 乙酸乙酯 作用下， 生成 3,4-二氢异喹啉-1(2H)-酮
  参考文献：
  名称：

  Beiträge zur Chemie der Carbinolamine II. Synthesen von Hydroisocarbostyrilen

  摘要：

  DOI：

  10.1002/ardp.19582911105

文献信息

• Npy antagonists, preparation and uses
  申请人：Botez Iuliana

  公开号：US20090233910A1

  公开（公告）日：2009-09-17

  The present invention concerns novel compounds, their preparation and their uses, therapeutic uses in particular. More specifically it concerns derivative compounds having at least two aromatic cycles, their preparation and their uses, in particular in the area of human or animal health. These compounds have an affinity for the biological receptors of neuropeptide Y, NPY, present in the central and peripheral nervous systems. The compounds of the invention are preferably NPY antagonists, and more particularly antagonists of sub-type NPY Y1, and can therefore be used for the therapeutic or prophylactic treatment of any disorder involving NPY. The present invention also concerns pharmaceutical compositions containing said compounds, their preparation and their uses, as well as treatment methods using said compounds.

  本发明涉及新颖化合物，它们的制备和用途，特别是在治疗方面的用途。更具体地说，它涉及至少具有两个芳香环的衍生化合物，它们的制备和用途，特别是在人类或动物健康领域。这些化合物对存在于中枢和外周神经系统中的神经肽Y（NPY）的生物受体具有亲和力。本发明的化合物优选为NPY拮抗剂，更具体地说是NPY Y1亚型的拮抗剂，因此可用于治疗或预防涉及NPY的任何疾病。本发明还涉及含有所述化合物的药物组合物，其制备和用途，以及使用所述化合物的治疗方法。
• Clean and Efficient Benzylic C−H Oxidation in Water Using a Hypervalent Iodine Reagent: Activation of Polymeric Iodosobenzene with KBr in the Presence of Montmorillonite-K10
  作者：Toshifumi Dohi、Naoko Takenaga、Akihiro Goto、Hiromichi Fujioka、Yasuyuki Kita

  DOI：10.1021/jo8012435

  日期：2008.9.19

  We have found that unreactive and insoluble polymeric iodosobenzene [PhIO] n induced aqueous benzylic C-H oxidation to effectively give arylketones, in the presence of KBr and montmorillonite-K10 (M-K10) clay. Water-soluble and reactive species 1 having the unique I(III)-Br bond, in situ generated from [PhIO]n and KBr, was considered to be the key radical initiator during the reactions.

  我们已经发现，在KBr和蒙脱土-K10（M-K10）粘土的存在下，不活泼且不溶的聚合碘代苯[PhIO] n可以诱导苄基CH水溶液氧化，从而有效地产生芳基酮。由PhIOn和KBr原位产生的具有独特的I（III）-Br键的水溶性和反应性物质1被认为是反应过程中的关键自由基引发剂。
• [EN] AMINE-LINKED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION<br/>[FR] DÉGRONIMÈRES DE C3-GLUTARIMIDE LIÉS À UNE AMINE POUR LA DÉGRADATION DE PROTÉINES CIBLES
  申请人：C4 THERAPEUTICS INC

  公开号：WO2017197051A1

  公开（公告）日：2017-11-16

  This invention provides amine-linked C3-glutarimide Degronimers and Degrons for therapeutic applications as described further herein, and methods of use and compositions thereof as well as methods for their preparation.

  这项发明提供了胺连接的C3-戊二酰亚胺Degronimers和Degrons，用于治疗应用，如本文进一步描述的，以及它们的使用方法、组合物以及它们的制备方法。
• <i>Ex Situ</i> Generation of Stoichiometric and Substoichiometric ¹²CO and ¹³CO and Its Efficient Incorporation in Palladium Catalyzed Aminocarbonylations
  作者：Philippe Hermange、Anders T. Lindhardt、Rolf H. Taaning、Klaus Bjerglund、Daniel Lupp、Troels Skrydstrup

  DOI：10.1021/ja200818w

  日期：2011.4.20

  CO-precursor led to the development of a new solid, stable, and easy to handle source of CO for chemical transformations. The synthesis of this CO-precursor also provided an entry point for the late installment of an isotopically carbon-labeled acid chloride for the subsequent release of gaseous [(13)C]CO. In combination with studies aimed toward application of CO as the limiting reagent, this method provided

  使用简单的密封两室系统实现了异位生成一氧化碳 (CO) 及其在钯催化的羰基化反应中的有效结合的新技术。CO 的异位生成是通过钯催化的叔酰氯脱羰使用源自 Pd(dba)(2) 和 P(tBu)(3) 的催化剂产生的。使用新戊酰氯作为 CO 前体的初步研究为仅使用 1.5 当量的 CO 对 2-吡啶基甲苯磺酸酯衍生物进行氨基羰基化提供了另一种方法。 酰氯 CO 前体的进一步设计导致开发了一种新的固体、稳定、并且易于处理用于化学转化的 CO 源。这种 CO 前体的合成也为后期安装同位素碳标记的酰氯以随后释放气态 [(13)C]CO 提供了切入点。结合旨在应用 CO 作为限制剂的研究，该方法提供了高效的钯催化氨基羰基化，CO 结合率高达 96%。异位生成的 CO 和双室系统在几种药物化合物的合成中进行了测试，所有这些化合物都被标记为 [(13)C] 羰基对应物，基于限制 CO 的产率从良好到极好。
• [EN] COMPOUNDS USEFUL AS CSF1 MODULATORS<br/>[FR] COMPOSÉS UTILES EN TANT QUE MODULATEURS DU FACTEUR 1 DE STIMULATION DE COLONIES
  申请人：REDX PHARMA PLC

  公开号：WO2016051193A1

  公开（公告）日：2016-04-07

  This invention relates to novel compounds and to pharmaceutical compositions comprising the novel compounds. More specifically, the invention relates to compounds useful as Colony Stimulating Factor 1 Receptor (cFMS) modulators (e.g. cFMS inhibitors). This invention also relates to processes for preparing the compounds, uses of the compounds in treatment and methods of treatment employing the compounds. Specifically, the invention relates to the use of the compounds for the treatment of cancer and autoimmune diseases.

  这项发明涉及新颖化合物以及包含这些新颖化合物的药物组合物。更具体地，该发明涉及用作集落刺激因子1受体（cFMS）调节剂（例如cFMS抑制剂）的化合物。这项发明还涉及制备这些化合物的方法，这些化合物在治疗中的用途以及利用这些化合物进行治疗的方法。具体而言，该发明涉及利用这些化合物治疗癌症和自身免疫性疾病。